Literature DB >> 26040945

Atypical femur fractures in a patient with pycnodysostosis: a case report.

J Hashem1, R Krochak, M D Culbertson, C Mileto, H Goodman.   

Abstract

Pycnodysostosis is a rare autosomal recessive disease due to a mutation in the gene for the enzyme Cathepsin K. It is characterized by short stature, craniofacial dysmorphias, osteosclerosis, and brittle bones. There are only a few reports in the literature describing surgical interventions for long bone fractures in pycnodysostosis patients, most of which describe intramedullary nail treatment of isolated long bone fractures. We describe a case in which a pregnant female with pycnodysostosis presented with a shaft fracture of the left femur following minor trauma and a history of increasing thigh pain. Radiographs obtained in the emergency room also revealed an impending subtrochanteric fracture of the contralateral side. The acute left femoral shaft fracture was treated with an adolescent-sized intramedullary nail; it was decided to defer surgery on the contralateral side until after pregnancy. Three months later, the patient had the contralateral femur prophylactically fixated with a plate and screws. One year after the index surgery, both methods demonstrated satisfactory healing both clinically and radiographically. Although we recommend use of an intramedullary nail for long bone fractures in patients with pycnodysostosis, a plate can be utilized if health conditions or skeletal morphology precludes use of a nail.

Entities:  

Mesh:

Year:  2015        PMID: 26040945     DOI: 10.1007/s00198-015-3191-1

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  16 in total

Review 1.  Insights into material and structural basis of bone fragility from diseases associated with fractures: how determinants of the biomechanical properties of bone are compromised by disease.

Authors:  P Chavassieux; E Seeman; P D Delmas
Journal:  Endocr Rev       Date:  2006-12-19       Impact factor: 19.871

2.  Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate.

Authors:  Brett A Lenart; Dean G Lorich; Joseph M Lane
Journal:  N Engl J Med       Date:  2008-03-20       Impact factor: 91.245

3.  An atypical subtrochanteric femoral fracture from pycnodysostosis: a lesson from nature.

Authors:  Christopher J Yates; Miriam J Bartlett; Peter R Ebeling
Journal:  J Bone Miner Res       Date:  2011-06       Impact factor: 6.741

4.  Pycnodysostosis.

Authors:  Z Emami-Ahari; M Zarabi; B Javid
Journal:  J Bone Joint Surg Br       Date:  1969-05

5.  Surgical outcomes after treatment of fractures in femur and tibia in pycnodysostosis.

Authors:  T Nakase; N Yasui; K Hiroshima; K Ohzono; C Higuchi; N Shimizu; H Yoshikawa
Journal:  Arch Orthop Trauma Surg       Date:  2006-12-30       Impact factor: 3.067

6.  Orthopaedic problems in patients with pycnodysostosis.

Authors:  G Lyritis; A Rapidis; B Dimitracopoulos
Journal:  Prog Clin Biol Res       Date:  1982

7.  Fracture management in pycnodysostosis: 27 years of follow-up.

Authors:  Noam Bor; Guy Rubin; Nimrod Rozen
Journal:  J Pediatr Orthop B       Date:  2011-03       Impact factor: 1.041

8.  Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution.

Authors:  S-K Goh; K Y Yang; J S B Koh; M K Wong; S Y Chua; D T C Chua; T S Howe
Journal:  J Bone Joint Surg Br       Date:  2007-03

9.  Subtrochanteric fracture managed by intramedullary nail in a patient with pycnodysostosis.

Authors:  Zile Singh Kundu; Kirta Mohan Marya; Ashish Devgan; Vikas Yadav; Seema Rohilla
Journal:  Joint Bone Spine       Date:  2004-03       Impact factor: 4.929

Review 10.  Clinical and animal research findings in pycnodysostosis and gene mutations of cathepsin K from 1996 to 2011.

Authors:  Yang Xue; Tao Cai; Songtao Shi; Weiguang Wang; Yanli Zhang; Tianqiu Mao; Xiaohong Duan
Journal:  Orphanet J Rare Dis       Date:  2011-05-10       Impact factor: 4.123

View more
  8 in total

1.  Genetic study of eight Egyptian patients with pycnodysostosis: identification of novel CTSK mutations and founder effect.

Authors:  G A Otaify; M S Abdel-Hamid; M I Mehrez; E Aboul-Ezz; M S Zaki; M S Aglan; S A Temtamy
Journal:  Osteoporos Int       Date:  2018-05-23       Impact factor: 4.507

Review 2.  Cathepsin K Inhibitors for Osteoporosis: Biology, Potential Clinical Utility, and Lessons Learned.

Authors:  Matthew T Drake; Bart L Clarke; Merry Jo Oursler; Sundeep Khosla
Journal:  Endocr Rev       Date:  2017-08-01       Impact factor: 19.871

Review 3.  Orthopedic Treatment of Pycnodysostosis: A Systematic Review.

Authors:  Taha M Taka; Brandon Lung; Hayk Stepanyan; David So; Steven Yang
Journal:  Cureus       Date:  2022-04-19

Review 4.  Traumatic cervical spine injuries in a patient with pycnodysostosis.

Authors:  Khaled Zitouna; Myriam Jrad; Mehdi Miladi; Maher Barsaoui; Ghassen Drissi; Mohamed Lassaad Kanoun
Journal:  Eur J Orthop Surg Traumatol       Date:  2018-02-26

5.  A case report of pycnodysostosis with atypical femur fracture diagnosed by next-generation sequencing of candidate genes.

Authors:  Hyung Keun Song; Young Bae Sohn; Yong Jun Choi; Yoon-Sok Chung; Ja-Hyun Jang
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

6.  Increased Bone Resorption during Lactation in Pycnodysostosis.

Authors:  Ineke D C Jansen; Socrates E Papapoulos; Nathalie Bravenboer; Teun J de Vries; Natasha M Appelman-Dijkstra
Journal:  Int J Mol Sci       Date:  2021-02-11       Impact factor: 5.923

7.  Bisphosphonate therapy associated with bilateral atypical femoral fracture and delayed union.

Authors:  István Gárgyán; Dávid Dózsai; István Csonka; Ferenc Rárosi; Tamás Bodzay; Ákos Csonka
Journal:  Jt Dis Relat Surg       Date:  2022-03-28

Review 8.  Genetic Risk Factors for Atypical Femoral Fractures (AFFs): A Systematic Review.

Authors:  Hanh H Nguyen; Denise M van de Laarschot; Annemieke JMH Verkerk; Frances Milat; M Carola Zillikens; Peter R Ebeling
Journal:  JBMR Plus       Date:  2018-01-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.